Phase I trial of gemcitabine and paclitaxel in advanced solid tumors. - Wikidata - awgldk - TriplyDB

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

http://www.wikidata.org/entity/Q33347008

about

Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer.

P2860

Q38826034-1A42E006-3452-43D6-A968-05DA5E2FC2BC

P2860

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

http://www.wikidata.org/entity/Q33347008

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

@ast

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

@en

type

label

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

@ast

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

@en

prefLabel

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

@ast

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

@en

P1433

Q33347008-19C8C864-1B70-4248-9111-F8E53AB079C7

P1476

Q33347008-1DEA72B0-7B32-4EE1-88BE-9424C828A6E8

P2093

Q33347008-21F526D1-588B-4363-87A3-BF750D417AF4

Q33347008-2272D48F-0296-4F7F-9624-07888C5400D5

Q33347008-7D36DB32-08A4-4481-BFE9-0B59294C8DF4

Q33347008-93277B74-2B95-421A-9EF0-D275C0C1895F

Q33347008-A0638F04-F71A-46C1-BF83-6863E26C5DBD

Q33347008-B1C96C48-AB12-445D-B806-281B83595EE3

Q33347008-C269F678-4109-49AC-8AA8-D8B4A480006D

Q33347008-CB714810-7888-4744-9CBC-80023189A7F6

P2860

Q33347008-11AE7AE3-DE07-4A32-A4F9-ABFEF79E66E4

Q33347008-43355476-5F45-4944-B8F8-19EEFDAF6612

Q33347008-63B3A43B-87A4-4CA8-9568-8C64058FAC55

Q33347008-7BF65694-3C23-46CE-98F8-8CDEDDA22153

Q33347008-A060040B-FCA5-4C97-8CFE-E4D1873822C7

Q33347008-EBD11177-AAE7-4085-98DA-267087F7861C

P304

Q33347008-10121DA1-B16F-4607-8874-89C71994B65A

P31

Q33347008-620912D4-DDDA-402B-9F07-C147FF8F7B7B

P356

Q33347008-00926844-EA65-4DEF-8EBF-9B79E9E5FDCE

P433

Q33347008-6A3D21C7-9000-427B-A564-1810365DC871

P478

Q33347008-03DAC7BE-AD86-422D-A7B2-84C030B982C0

P50

Q33347008-7146C82E-05B4-45C1-954A-300ADCE095BF

P577

Q33347008-F89BE808-3C39-4F59-BAE3-95C30B2E35B6

P698

Q33347008-817583E7-9205-4911-A700-DEA9EACE8C6C

P921

Q33347008-65D56310-0EA8-47BD-BB12-D83FFF0C70CA

P356

P1433

Cancer Investigation

P1476

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors.

@en

P2093

Derick H M Lau

http://www.w3.org/2001/XMLSchema#string

Ghassan al-Jazayrly

http://www.w3.org/2001/XMLSchema#string

Ignacio Lauder

http://www.w3.org/2001/XMLSchema#string

Joan Houston

http://www.w3.org/2001/XMLSchema#string

Martin J Edelman

http://www.w3.org/2001/XMLSchema#string

Michael Tanaka

http://www.w3.org/2001/XMLSchema#string

Nelson Lim

http://www.w3.org/2001/XMLSchema#string

Primo N Lara

http://www.w3.org/2001/XMLSchema#string

P2860

Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group.

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.

Paclitaxel (taxol)

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.

Phase I study of gemcitabine using a once every 2 weeks schedule.

Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies.

P304

7-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/CNV-120016398

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

David R Gandara

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12643004

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial